Literature DB >> 29210531

Comparison of endoscopic and open resection of sinonasal squamous cell carcinoma: a propensity score-matched analysis of 652 patients.

Suat Kılıç1, Sarah S Kılıç2, Soly Baredes1,3, Richard Chan Woo Park1, Omar Mahmoud2, Jeffrey D Suh4, Stacey T Gray5,6, Jean Anderson Eloy1,3,7,8.   

Abstract

BACKGROUND: The use of endoscopic resection as an alternative to open surgery for sinonasal malignancies has increased in the past 20 years.
METHODS: The National Cancer Database was queried for cases of sinonasal squamous cell carcinoma (SNSCC) without cervical or distant metastases that were treated surgically between 2010 and 2014. They were split into 2 groups based on surgical approach: open or endoscopic. Demographics, facility and insurance type, stage, tumor characteristics, postoperative treatment, 30-day readmission rate, 30- and 90-day mortality, and overall survival (OS) were compared between the 2 groups. Cox proportional hazard analysis was performed. Propensity score matching (PSM) was used to mimic a randomized, controlled trial.
RESULTS: A total of 1,483 patients were identified: 353 (23.8%) received endoscopic and 1130 (76.2%) received open surgery. Age, gender, race, geographic region, tumor size, surgical margins, postoperative chemoradiation, and 30-day readmissions did not vary significantly between the 2 groups. Open surgery was more common in academic centers (62.8% vs 54.2%; p = 0.004), less common for tumors of the ethmoid and sphenoid sinus (p < 0.0001), less common for stage IVB tumors, and associated with longer hospital stay (mean, 4.67 days vs 2.50 days; p < 0.0001). Five-year OS (5Y-OS) was not significantly different between the 2 approaches (p = 0.953; open: 5Y-OS, 56.5%; 95% confidence interval, 51.3% to 61.6%; endoscopic: 5Y-OS, 46.0%; 95% confidence interval, 33.2% to 58.8%). In the PSM cohort of 652 patients, there was also no significant difference in OS (p = 0.850).
CONCLUSION: Endoscopic surgery is an effective alternative to open surgery, even after accounting for confounding factors that may favor its use over the open approach. It is also associated with a shorter hospital stay.
© 2017 ARS-AAOA, LLC.

Entities:  

Keywords:  NCDB; National Cancer Database; endoscopic; nasal cavity; open; propensity score matched; sinonasal cancer; sinus; squamous cell carcinoma; survival

Mesh:

Year:  2017        PMID: 29210531     DOI: 10.1002/alr.22040

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  8 in total

Review 1.  Management of squamous cell carcinomas of the skull-base.

Authors:  Colin G Leonard; Vikram Padhye; Ian J Witterick
Journal:  J Neurooncol       Date:  2020-06-05       Impact factor: 4.130

Review 2.  Carotid artery injury in endoscopic endonasal surgery: Risk factors, prevention, and management.

Authors:  Rahul K Sharma; Alexandria L Irace; Jonathan B Overdevest; David A Gudis
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2022-03-22

3.  Prognostic Analysis of HPV Status in Sinonasal Squamous Cell Carcinoma.

Authors:  Alexandre Tendron; Marion Classe; Odile Casiraghi; Hélène Pere; Caroline Even; Philippe Gorphe; Antoine Moya-Plana
Journal:  Cancers (Basel)       Date:  2022-04-08       Impact factor: 6.575

Review 4.  The Selective Role of Open and Endoscopic Approaches for Sinonasal Malignant Tumours.

Authors:  Fernando López; Jatin P Shah; Jonathan J Beitler; Carl H Snyderman; Valerie Lund; Cesare Piazza; Antti A Mäkitie; Orlando Guntinas-Lichius; Juan P Rodrigo; Luiz P Kowalski; Miquel Quer; Ashok Shaha; Akihiro Homma; Alvaro Sanabria; Renata Ferrarotto; Anne W M Lee; Victor H F Lee; Alessandra Rinaldo; Alfio Ferlito
Journal:  Adv Ther       Date:  2022-03-30       Impact factor: 4.070

5.  Endoscopic Fluorescence-Guided Surgery for Sinonasal Cancer Using an Antibody-Dye Conjugate.

Authors:  Zachary P Hart; Naoki Nishio; Giri Krishnan; Guolan Lu; Quan Zhou; Shayan Fakurnejad; Peter John Wormald; Nynke S van den Berg; Eben L Rosenthal; Fred M Baik
Journal:  Laryngoscope       Date:  2019-12-19       Impact factor: 3.325

6.  Outcomes of Management of Sinonasal Malignancies at a Dedicated Cancer Institution: A Retrospective Study.

Authors:  Rahim Dhanani; Muhammad Faisal; Hamza Shahid; Kashif Iqbal Malik; Arif Jamshed; Raza Hussain
Journal:  Ann Maxillofac Surg       Date:  2021-07-24

7.  Oncologic outcome of multimodality treatment for sinonasal malignancies: An 18-year experience.

Authors:  Meng-Yu Chen; Xin Wen; Yi Wei; Lin Chen; Zi-Xuan Huang; Tong Lu; Nian-Zhen Zheng; Jian Li; Wei-Ping Wen; Yi-Hui Wen
Journal:  Front Oncol       Date:  2022-09-05       Impact factor: 5.738

8.  Treatment Outcomes of Maxillary Sinus Squamous Cell Carcinoma at a Dedicated Cancer Institute: A Retrospective Study.

Authors:  Ahmed A Keerio; Muhammad U Qayyum; Alina Kashif; Rahim Dhanani; Asma Rashid; Muhammad Faisal; Raza Hussain; Arif Jamshed
Journal:  Cureus       Date:  2022-06-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.